Highlights
C&EN: Copper finally joins the metallocene club
17 February 2026More than 70 years after ferrocene’s discovery, cuprocene fills a long-standing gap in the sandwich menu.
C&EN: Lighting a better path for biobased furans
16 January 2026Photocatalytic hydrolysis offers a shortcut for renewable chemicals.
C&EN: Gas looping boosts efficiency of carbon nanotube production
22 December 2025Methane pyrolysis reactor recycles process gases to improve output of nanotubes and hydrogen.
C&EN: Enhanced rock weathering shows little climate benefit in large trial
18 December 20253-year Swiss study underscores the importance of site selection to maximize CO2 sequestration.
Nature Nanotechnology: Brain–computer interfaces race to the clinic
12 December 2025Advances in materials science, microelectronics and semiconductor manufacturing are helping these devices to benefit patients.
TESTIMONIALS
“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Philip Ball
Freelance Science Writer
Author Archives: Mark Peplow
Crusading editor aims to shake things up in science
A profile of the BMJ’s editor, Fiona Godlee, for STAT magazine.
Posted in Profile
Comments Off on Crusading editor aims to shake things up in science
Malaria drug meets market resistance
Exclusive news article for Nature about artemisinin.
Posted in News reporting
Comments Off on Malaria drug meets market resistance
The hole story
Nature article about Swiss-cheese-like materials called metal–organic frameworks.
Posted in Feature reporting
Comments Off on The hole story
Nature: Liquid metal ‘balloons’ offer room-temperature soldering
Invention could help the microelectronics industry to connect circuit-board components without risking heat damage.
Posted in Highlights
Comments Off on Nature: Liquid metal ‘balloons’ offer room-temperature soldering
Chemical & Engineering News: Tiny enzyme tweak expands substrate palette
Changing just two amino acids transforms a picky aldolase into a cosmopolitan catalyst.
Posted in Highlights
Comments Off on Chemical & Engineering News: Tiny enzyme tweak expands substrate palette
Nature: Synthetic malaria drug meets market resistance
First commercial deployment of synthetic biology for medicine has modest impact.
Posted in Highlights
Comments Off on Nature: Synthetic malaria drug meets market resistance
ACS Central Science: A Conversation with Christina Smolke
The synthetic biology pioneer discusses how she reprogrammed yeast to produce opioids.
Posted in Highlights
Comments Off on ACS Central Science: A Conversation with Christina Smolke
Chemistry World: The toxic tale of the Flint water crisis
The city’s dilemma highlights serious regulatory failings but demonstrates the empowerment offered by citizen science.
Posted in Highlights
Comments Off on Chemistry World: The toxic tale of the Flint water crisis
Chemistry World: A farewell to chemical arms
As chemical weapons stockpiles dwindle, international efforts must guard against renewed arsenals.
Posted in Highlights
Comments Off on Chemistry World: A farewell to chemical arms
ACS Central Science: A Conversation with Kristopher McNeill
The environmental chemist hopes to reduce our impact on the planet by planning ways to tackle pollution before it happens.
Posted in Highlights
Comments Off on ACS Central Science: A Conversation with Kristopher McNeill
